Phase 2 study of subcutaneous omacetaxine mepesuccinate after TKI failure in patients with chronic-phase CML with T315I mutation (Q33402841)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Phase 2 study of subcutaneous omacetaxine mepesuccinate after TKI failure in patients with chronic-phase CML with T315I mutation |
scientific article |
Statements
1 reference
Phase 2 study of subcutaneous omacetaxine mepesuccinate after TKI failure in patients with chronic-phase CML with T315I mutation (English)
1 reference
Hagop Kantarjian
1 reference
Jorge Cortes
1 reference
Jeff H Lipton
1 reference
Raghunadharao Digumarti
1 reference
Charles Chuah
1 reference
Nisha Nanda
1 reference
Annie-Claude Benichou
1 reference
Mauricette Michallet
1 reference
Adam R Craig
1 reference
Franck E Nicolini
1 reference
Omacetaxine 202 Study Group
1 reference
15 August 2012
1 reference
1 reference
120
1 reference
13
1 reference
2573-2580
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference